Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ProMIS Neurosciences Inc. quarterly Debt-to-equity history and growth rate from Q1 2023 to Q3 2024.
ProMIS Neurosciences Inc. Debt-to-equity for the quarter ending September 30, 2024 was 388 %.
Debt-to-equity, Quarterly (%)
Period
Value
YoY Chg
Change %
Date
Q3 2024
388
+819
Sep 30, 2024
Q2 2024
339
+558
Jun 30, 2024
Q1 2024
1.68K
+32.7K
Mar 31, 2024
Q4 2023
-991
Dec 31, 2023
Q3 2023
-430
Sep 30, 2023
Q2 2023
-219
Jun 30, 2023
Q1 2023
-31K
Mar 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.